dovetail biopartners

The first full week of 2025 is here. While I’m unsure what the year will bring, I’m hopeful it brings more stories of companies raising funds, successful exits, and people landing new opportunities compared to last year. What I do know is that the hustle is back in the air with the holidays over and #JPM2025 right around the corner. At dovetail biopartners, 2025 is set to be a year of significant growth and innovation as we continue building on the momentum we created in 2024. Our mission remains the same: to empower life sciences companies with tools, strategies, and insights that turn complex data into clear, actionable outcomes. From transforming data management and streamlining bioinformatics to developing algorithms and custom dashboards, we’re here to help our clients make smarter, faster decisions. This year, we’re also also focused on building unique tools to augment our services... and I don't think that what we're building has been done before by a data science consulting company. We'll be a consulting-first platform company. We can’t wait to share what’s ahead. Those of you at #JPM2025 will get to see a demo! And you will all get a sneak peak of the new Buzzed for Biotech rebrand and networking app this week! BIG things are happening. 👉 If you want to meet up at JPM - ping me here or at daniel.dacey@dovetailbp.com

Excited to share a unique sponsorship opportunity during #JPM2025! This will technically be the first event of the new year for Buzzed for Biotech, and it’s not your typical big conference gathering. While the large events are fun and worth attending, the true value lies in smaller, curated settings where you can genuinely connect with others—learning about their goals and passions without having to shout over a crowd of 500. These intimate conversations set the stage for much more impactful follow-ups after JPM. That’s why Lisa Yu and I are hosting an exclusive dinner for 30 on January 14th in a stunning 55th-floor penthouse in San Francisco. So far, we’ve confirmed 20 exceptional attendees—half VCs and half executives, founders, and prominent leaders in the #biotech, #AI, and #healthtech. This is a rare opportunity to engage directly with decision-makers and explore partnerships that could drive smarter strategies to advance research and improve patient outcomes. To make it happen... 👉 We need a couple more sponsors 👈 If this intrigues you, leave a comment or shoot me a message!

Meet Daniel Dacey in the Bullpen during JPM Week 2025 January 12 - 16 in San Francisco. #JPM2025 Request an Invitation: https://lnkd.in/gcXNSkBA #Bullpen HQ is located at the Golden Gate Yacht Club, home to America's Cup Champion Oracle Team USA. Request an invitation to join us for Gourmet Meals, Investor-Only Meetings, Bullpen Cup Pitches, 1:1 Partnering, KOL Interviews, Golden Gate Bridge Boat Rides and Sunset Happy Hours while gazing directly at the Golden Gate Bridge. #Mantra: Find Someone to Help. Repeat. Bullpen is an invite-only Club gathering Life Science Investors and CxOs with the shared goal of helping each other. We prepare for and attend premier industry events together. 2024 JPM Photos: https://lnkd.in/g6GrGDmY Thank you to our Lead Partners: Ben Kromnick at Mercury Ernesto Chanona at CSSi LifeSciences Jill Sorensen at MTEC | Medical Technology Enterprise Consortium Lisa Cavallaro at Brisbane Economic Development Agency (BEDA) Caley Anderson, MBA at Collaborative Drug Discovery - CDD Vault Jess Hawthorne at CSC Leasing Phillip Ebner at J.P. Morgan James Zanewicz, JD, LLM, RTTP at BIO on the BAYOU Anton Xavier at Silicon Valley Bank Laura Haldane at SciLeads

dovetail biopartners is officially an Approved Supplier on Scientist.com! [Their due diligence process is no joke!] Becoming an approved supplier on Scientist.com—a leading marketplace for life sciences innovation—is a major milestone. This recognition signifies that we meet the high standards required to be part of a trusted network used by #biotech and #pharma companies worldwide. But it creates a streamlined way for us to connect with organizations pushing the boundaries of science. With less paperwork, we can deliver our tailored data solutions—ranging from #bioinformatics pipelines to #AI-driven insights—faster and more efficiently, helping to tackle complex challenges in pre-clinical and clinical research. Building a company is a journey, and as a founder wearing many hats—from CEO to salesperson—I’ve prioritized building trust through hosting events and fostering connections in the biotech community. This personal approach has helped establish dovetail biopartners as a trusted name. At the same time, I believe in diversifying growth strategies. Platforms like Scientist.com and targeted cold outreach (I hate doing this but it's a necessity) play a key role in amplifying our impact and connecting with organizations that can benefit from what we offer. ⚫ Fellow founders and business development professionals—I’m always looking to exchange ideas and learn what’s working for others. ⚫ Researchers and biotech leaders—if you know your data processes and #translationalbiology efforts could be more efficient, let’s connect to discuss strategies for optimizing your infrastructure and workflows to achieve your goals.

Managing data teams effectively requires more than just hiring skilled scientists and bioinformaticians. It demands time, capital, and expertise to align their efforts with your goals. If you don’t have a data expert in a senior leadership position or the infrastructure to keep those teams focused and aligned, things can quickly spiral into inefficiency. We see this all the time at dovetail biopartners. Sometimes, we step in as the data team, building solutions from the ground up. Other times, we partner with existing teams—not to replace them, but to help them reach their full potential. How? 🔹 Turn chaos into clarity. Disorganized datasets or scaling infrastructure don’t have to be roadblocks. With tools like bioinformatics frameworks and cloud infrastructure, data can become accessible, actionable, and transformative. 🔹 Prioritize seamless integration. Solutions should align with existing workflows, enhancing pipelines and enabling the development of ML models without creating additional complexity. 🔹 Focus on partnerships, not handoffs. Effective solutions require ongoing support. Post-delivery collaboration ensures results are practical, scalable, and adaptable to evolving needs. 🔹 Deliver measurable results. Success comes from driving outcomes that matter—whether it’s accelerating go/no-go decisions or identifying new therapeutic targets. 🔹 Build for sustainability. Foundational data governance, predictive analytics, and scalable systems are the keys to long-term innovation and efficiency. The goal is to provide the frameworks, insights, and expertise to help teams move faster, work smarter, and deliver better outcomes. When research progresses efficiently, innovation becomes inevitable. Let us help get you there. Jump on a call with me here to learn more: https://lnkd.in/eaQCdaJC #datascience #ml #ai #translationalbiology #biotech

Last night’s 𝐁𝐨𝐬𝐭𝐨𝐧 𝐏𝐢𝐭𝐜𝐡𝐅𝐞𝐬𝐭 – 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐄𝐝𝐢𝐭𝐢𝐨𝐧 was an incredible success! 🚀 Buzzed for Biotech's largest event to date! Over 60 startups pitched groundbreaking ideas in therapeutics, diagnostics, and platforms to diverse investor panels in private sessions, while more than 200 attendees networked throughout the beautiful Portal Innovations, LLC Innovations building. The finalists took the stage to pitch in front of the larger audience, and we crowned 3 winners who earned exclusive access to Biotechnology Innovation Organization Partnering at #JPM2025 courtesy of Mackensie V.. 🏆 𝐂𝐨𝐧𝐠𝐫𝐚𝐭𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐰𝐢𝐧𝐧𝐞𝐫𝐬! Luca Giani of Ilios Therapeutics Avery (Qinghong) Yan, PhD of Riboway Therapeutics Brendan Walker of Chemeleon [I'll be working on getting you into some more exclusive dinners and parties as well!] Thank you to everyone for making this event such a success. Whether you were pitching, judging, or networking, I hope you walked away with valuable connections and fresh insights. A special shoutout to our sponsors who enabled this event: Leader Bank ➡️ Vitaliy Schafer & Alex Guinta. Also my co-hosts! dovetail biopartners ➡️ (this is me) Portal Innovations, LLC ➡️ Tatiana Yglesias Ulloa & Dan Goddard Pliancy ➡️ John Masland Collaborative Drug Discovery - CDD Vault ➡️ Ralf Felsner & Jeremy Shelley Ontologic ➡️ Eli Pollock & Joyce Wang Hamilton, Brook, Smith & Reynolds, P.C. ➡️ Chris Albert & Alexander Adam Egnyte ➡️ Abhay Kini & Bryant Donnowitz 🌟 and a HUGE shoutout to our volunteers who helped more than I could've imagined with controlling the flow of pitches throughout the event. Flora Hepp + Giselle Ventura + Arun Singh PhD + Sze-Wah 'Eva' Tse + Sepideh Ebadi Logistically, this event was a beast. Much tougher than I expected - you saved our ass*s! But now we know how to do it and the next pitch event will be event better. (A 3rd shoutout for our judges will come next week when we get the professional photos, stay tuned.) 𝐍𝐞𝐱𝐭 𝐔𝐩 𝐟𝐨𝐫 Buzzed for Biotech: 𝘛𝘩𝘦 𝘉𝘦𝘢𝘶𝘵𝘪𝘧𝘶𝘭 𝘞𝘢𝘺 𝘍𝘰𝘶𝘯𝘥𝘢𝘵𝘪𝘰𝘯’𝘴 1𝘴𝘵 𝘈𝘯𝘯𝘶𝘢𝘭 𝘊𝘰𝘯𝘷𝘦𝘳𝘨𝘦𝘯𝘤𝘦 𝘚𝘶𝘮𝘮𝘪𝘵 📅 Date: November 20, 2024 📍 Location: Portal Innovations, LLC, Boston, MA Join us for a day of panels, networking, and actionable discussions focused on advancing equity in clinical trials. Featuring keynote speakers, AI-focused panels, and the Pitch from the Heart Competition, this event is a must-attend for anyone passionate about healthcare innovation. 🎟️ Register here to secure your spot: https://lu.ma/n3t0c7kv See ya there! #biotech #lifesciences #pharma #networking #pitchcompetition #EquityInHealthcare

Today at 2 pm EST! We’re getting technical… Selecting the right sequencing approach is key to making informed go/no-go decisions in biotech research. Whether you’re testing a hypothesis or refining an experimental design, getting it right can make all the difference. At dovetail biopartners, we see these two transcriptomic data types—single-cell and bulk RNA sequencing—all the time and often find that people aren’t choosing the best approach for their specific needs. Our Co-Founder, Mikal El-Hajjar, will be discussing the critical differences between single-cell and bulk RNA sequencing. She’ll dive into the advantages and limitations of each method, sharing insights into how they can be applied in preclinical and clinical research to unlock unique biological insights—whether understanding cell population dynamics or analyzing cellular diversity. 👉 This is an interactive session designed to address your challenges. Bring your questions! RSVP here: https://lu.ma/c2mnvlk0 #biotech #lifesciences #datascience #rnaseq #transcriptomics #bioinformatics

If you're a biotech raising a Series A... come join us next week! 𝐁𝐨𝐬𝐭𝐨𝐧 𝐏𝐢𝐭𝐜𝐡𝐅𝐞𝐬𝐭 - 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐄𝐝𝐢𝐭𝐢𝐨𝐧 Therapeutics - Diagnostics - Platform November 14th 𝐓𝐰𝐨 𝐭𝐫𝐚𝐜𝐤𝐬: Pre-seed to Seed Seed to Series A We have 16 amazing executive and investor judges... ...over 35 investors who will be there just to network ...over 100 startups there to network ...40 others from large pharma and service providers ...over 50 companies pitching BUT... most are raising for Seed. 𝐖𝐄 𝐍𝐄𝐄𝐃 𝐌𝐎𝐑𝐄 𝐓𝐎 𝐏𝐈𝐓𝐂𝐇 𝐅𝐎𝐑 𝐓𝐇𝐄 𝐒𝐄𝐑𝐈𝐄𝐒 𝐀 𝐓𝐑𝐀𝐂𝐊 So spread the word. See you at Portal Innovations, LLC next Thursday! Thanks to our partners for making this event happen: dovetail biopartners - Leader Bank - Fidelity Investments - Collaborative Drug Discovery - CDD Vault - Pliancy - Hamilton, Brook, Smith & Reynolds, P.C., Portal Innovations, LLC

We are less than 2 weeks away from Boston Pitchfest: Biotech Edition! Excited to introduce our judges/investors who will be judging our Pre-Seed to Seed and Seed to Series A tracks. Alexander Adam Mary Ann Picard Dione Kobayashi Dan Goddard Gunes Bozkurt, PhD Megan Y. Lawrence Petit-Frere Ben Littauer (he/him) Chris Albert Ser-Chen Fu Shailesh Chavan Junaid Mian, RPh Kathleen Snyder Brittany Ryan Shout out to Portal Innovations, LLC for partnering with us to use their incredible space in South Boston (old Boston Globe HQ) as well as to all of the sponsors that are making this event possible. dovetail biopartners Pliancy Collaborative Drug Discovery - CDD Vault Hamilton, Brook, Smith & Reynolds, P.C. Fidelity Private Shares We are almost at capacity so register to attend or pitch before registrations close: https://lu.ma/trphyil9 This event would not be possible without our Co-Hosts and good friends Daniel Dacey and Kristen Craft who have helped curate such an exceptional list of investors and founders for the event. For any founders who would like additional resources to help you prepare to pitch - reach out to Alex Guinta or myself at Leader Bank.